We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




New Device Treats Acute Kidney Injury from Sepsis

By HospiMedica International staff writers
Posted on 15 Apr 2024
Print article
Image: The therapeutic tool can be used for children with kidney issues stemming from sepsis (Photo courtesy of 123RF)
Image: The therapeutic tool can be used for children with kidney issues stemming from sepsis (Photo courtesy of 123RF)

Sepsis, commonly referred to as "blood poisoning," can occur due to any infectious agent, triggering a systemic response by the body to combat the infection. This response involves the activation of circulating white blood cells. The critical severity of sepsis stems not from the infectious agent itself, but rather from the excessive and often detrimental response of white blood cells. When this response becomes uncontrolled and prolonged, these cells start to indiscriminately attack not only the pathogens but also the body’s own tissues. Until now, the options available for effectively treating sepsis were scarce. Now, a new, commercially viable method offers fresh hope to thousands of children suffering from acute kidney injury who develop this often deadly condition.

The therapeutic device has been invented and developed at the University of Michigan (Ann Arbor, MI, USA) for use in children with acute kidney injury and sepsis or a septic condition requiring continuous kidney replacement (dialysis with the artificial kidney) therapy in the intensive care unit. The device, known as the selective cytopheretic device (SCD) or Quelimmune, addresses the primary cause of death in septic patients, which is the uncontrolled and excessive inflammatory response that leads to the white blood cells damaging the body’s own organs.

The SCD is connected to a pump outside the body that pumps the blood through the device. The SCD selectively traps the dysregulated white cells, uses pharmacologic manipulation to calm the white cells, and then releases them back into the bloodstream. The effectiveness of this approach was validated by pooled data from two pediatric clinical trials, leading to its FDA approval in March 2024 for treating pediatric patients with severe sepsis and multiorgan failure. Given that more children die annually from sepsis than from all pediatric cancers combined, medical professionals are hopeful that SCD will significantly improve survival rates.

"Sepsis starts as a local infection, but once it gets into the bloodstream, there's a high mortality rate even if the patient starts an antibiotic,” said H. David Humes, MD, professor of nephrology and internal medicine. “Our technology focuses not on treating the bacteria, but treating this dysregulated immunologic system that is overreacting and destroying tissues within the body. That's the breakthrough with this technology.”

Related Links:
University of Michigan 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Anesthesia Workstation
X40

Print article

Channels

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.